Louisiana SB381 regulates pharmacy benefit managers by prohibiting certain practices and requiring specific actions.
Louisiana SB381 amends laws concerning pharmacy benefit managers (PBMs). It prohibits PBMs from obtaining rebates on brand name drugs in exchange for not placing generic drugs on their formulary. The bill also mandates that PBMs provide a 60-day continuity-of-care period when a drug is removed from the formulary, allowing insureds to continue receiving the drug at the same cost. Additionally, PBMs are prohibited from requiring insureds to receive drugs manufactured by an affiliated manufacturer when a generic equivalent is available.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.